Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
58
NMPA:58
Drug Approvals
Lamotrigine Dispersible Tablets
- Product Name
- 拉莫三嗪分散片
- Approval Number
- 国药准字H20233259
- Approval Date
- Jun 25, 2023
NMPA
Venlafaxine Hydrochloride Sustained-release Capsules
- Product Name
- 盐酸文拉法辛缓释胶囊
- Approval Number
- 国药准字H20233586
- Approval Date
- May 19, 2023
NMPA
Vitamin B Complex Injection
- Product Name
- 复合维生素B注射液
- Approval Number
- 国药准字H61023609
- Approval Date
- Mar 28, 2023
NMPA
Urapidil Sustained-release Capsules
- Product Name
- 乌拉地尔缓释胶囊
- Approval Number
- 国药准字H20070161
- Approval Date
- Nov 16, 2021
NMPA
Sodium Valproate Concentrated Solution for Injection
- Product Name
- 丙戊酸钠注射用浓溶液
- Approval Number
- 国药准字H20213394
- Approval Date
- May 19, 2021
NMPA
Sodium Valproate Concentrated Solution for Injection
- Product Name
- 丙戊酸钠注射用浓溶液
- Approval Number
- 国药准字H20213393
- Approval Date
- May 19, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found